The revenue generated by the North America Intrauterine contraceptive device market is projected to increase from $863 million in 2016 to $1156 million by 2025, because of an expected CAGR growth of 3.37% over the forecast period 2017-2025. The markets of countries like the United States and Canada were studied for this region. The market is primarily being driven by the high rate of unplanned pregnancies among the teenage population and by the initiatives undertaken by the government to reduce these unplanned pregnancies and abortion across the region.
NORTH AMERICA CONTRACEPTIVE MARKET FORECAST 2019-2027
North America Contraceptive Market by Education (Less Than High School, High School Graduate, College Graduate, Other College Degree) by Age Group (15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years) by End-user (Households, Clinics, Hospitals) by Drugs and Devices (Contraceptives Drugs, Contraceptive Devices) by Geography.
The North America market for contraceptive is estimated to grow from $XX billion in 2018 to $XX billion by 2027, at a CAGR of 6.49% between 2019 to 2027. North America dominated the overall market in terms of revenue and the United States market held the largest market share over the forecast period.
The rising customer awareness and government initiatives, the growing incidence of unwanted pregnancies and the swelling occurrence of sexually transmitted diseases (STD) are the chiefly driving the market growth in the region.
North America comprises three countries, namely, the United States and Canada. It has experienced a minimal change in the contraceptive methods use rates, and the usage has decreased by XX%. However, the region has the highest contraceptive prevalence, around XX%. Effective contraceptive methods such as pills, male condoms, IUDs, injectable, implants, and other modern barrier methods dominate this region. Several factors subsidize the growth of the market, for instance, the rapid increase in the world population, initiatives taken by the government; need to prevent young women from the unwanted pregnancies, and the increase in the incidence rate of STDs.
Afaxys, Inc., Pfizer, Inc., Church & Dwight Co., Inc., Allergan Inc., Apothecus Pharmaceutical Corporation, OCON Medical Ltd., Cooper Surgical Inc., Agile Therapeutics, Reckitt Benckiser PLC, Pregna, Mayer Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Merck & Co., Inc., and Okamoto Industries, Inc. are the major contending market players operating in North America, which have been profiled with intricate details in the report.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP-DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- COLLEGE GRADUATE HOLDS THE LARGEST MARKET SHARE IN TERMS OF EDUCATION
- AGE GROUP OF 15–24 YEARS IS ANTICIPATED TO GROW SIGNIFICANTLY
- HOUSEHOLDS ARE THE MAJOR END-USER
- CONTRACEPTIVES DEVICES ARE WIDELY USED
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- RISING CUSTOMER AWARENESS AND GOVERNMENT INITIATIVES
- GROWING INCIDENCE OF UNWANTED PREGNANCIES
- OCCURRENCE OF SEXUALLY TRANSMITTED DISEASES (STD)
- MARKET RESTRAINTS
- INCREASING AGING POPULATION
- SIDE EFFECTS ASSOCIATED WITH THE USE OF CONTRACEPTIVE DRUGS AND DEVICES
- MARKET OPPORTUNITIES
- INCREASE IN AWARENESS AND IMPORTANCE REGARDING FAMILY PLANNING
- STRATEGIC ALLIANCES AND INVESTING IN R&D
- MARKET CHALLENGES
- LACK OF PERCEPTION OF SOCIETY
- INCREASING COST AND INACCESSIBILITY OF CERTAIN HEALTH SERVICES
- MARKET BY EDUCATION
- LESS THAN HIGH SCHOOL
- HIGH SCHOOL GRADUATE
- COLLEGE GRADUATE
- OTHER COLLEGE DEGREES
- MARKET BY AGE GROUP
- 15–24 YEARS
- 25–34 YEARS
- 35–44 YEARS
- ABOVE 44 YEARS
- MARKET BY END-USER
- HOUSEHOLDS
- CLINICS
- HOSPITALS
- MARKET BY DRUGS AND DEVICES
- CONTRACEPTIVES DRUGS
- ORAL CONTRACEPTIVE PILLS
- INJECTABLE CONTRACEPTIVES
- TOPICAL CONTRACEPTIVES
- CONTRACEPTIVE DEVICES
- MALE CONDOMS
- FEMALE CONDOMS
- DIAPHRAGMS
- CONTRACEPTIVE SPONGES
- VAGINAL RINGS
- SUBDERMAL IMPLANTS
- INTRA-UTERINE DEVICES
- COPPER INTRA-UTERINE DEVICES
- HORMONAL INTRA-UTERINE DEVICES
- CONTRACEPTIVES DRUGS
- KEY ANALYTICS
- PORTER’S FIVE FORCES MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- THREAT OF COMPETITIVE RIVALRY
- PESTEL ANALYSIS
- MARKET TRENDS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCES MODEL
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- AFAXYS, INC.
- AGILE THERAPEUTICS
- ALLERGAN INC.
- APOTHECUS PHARMACEUTICAL CORPORATION
- BAYER AG
- CHURCH & DWIGHT CO., INC.
- COOPER SURGICAL, INC.
- MAYER LABORATORIES, INC.
- MERCK & CO., INC.
- OCON MEDICAL LTD.
- OKAMOTO INDUSTRIES, INC.
- PFIZER, INC.
- PREGNA
- RECKITT BENCKISER PLC
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
TABLE LIST
TABLE 1 NORTH AMERICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
TABLE 2 ASSOCIATED SIDE EFFECTS FOR DIFFERENT CONTRACEPTIVE METHOD
TABLE 3 NORTH AMERICA CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA LESS THAN HIGH SCHOOL MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA HIGH SCHOOL GRADUATE MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA COLLEGE GRADUATE MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA OTHER COLLEGE DEGREES MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA 15–24 YEARS MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA 25–34 YEARS MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA 35–44 YEARS MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA ABOVE 44 YEARS MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA CONTRACEPTIVE MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA HOUSEHOLDS MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA ORAL CONTRACEPTIVE PILLS MARKET 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA INJECTABLE CONTRACEPTIVES MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA TOPICAL CONTRACEPTIVES MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 25 NORTH AMERICA MALE CONDOMS MARKET 2019-2027 ($ MILLION)
TABLE 26 NORTH AMERICA FEMALE CONDOMS MARKET 2019-2027 ($ MILLION)
TABLE 27 NORTH AMERICA DIAPHRAGMS MARKET 2019-2027 ($ MILLION)
TABLE 28 NORTH AMERICA CONTRACEPTIVE SPONGES MARKET 2019-2027 ($ MILLION)
TABLE 29 NORTH AMERICA VAGINAL RINGS MARKET 2019-2027 ($ MILLION)
TABLE 30 NORTH AMERICA SUBDERMAL IMPLANTS MARKET 2019-2027 ($ MILLION)
TABLE 31 NORTH AMERICA INTRA-UTERINE DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 32 NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 33 NORTH AMERICA COPPER INTRA-UTERINE DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 34 NORTH AMERICA HORMONAL INTRA-UTERINE DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 35 NORTH AMERICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
TABLE 36 NORTH AMERICA CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 37 THE UNITED STATES CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 38 CANADA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
FIGURE LIST
FIGURE 1 NORTH AMERICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA CONTRACEPTIVE MARKET SHARE BY EDUCATION 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA CONTRACEPTIVE MARKET SHARE BY AGE GROUP 2018 & 2027 (%)
FIGURE 8 NORTH AMERICA CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA CONTRACEPTIVE MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 13 NORTH AMERICA CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA CONTRACEPTIVE MARKET SHARE BY DRUGS AND DEVICES 2018 & 2027 (%)
FIGURE 17 NORTH AMERICA CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)
FIGURE 25 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)
FIGURE 26 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)
FIGURE 27 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)
FIGURE 28 NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 29 NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 30 NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 31 PORTER’S FIVE FORCE MODEL
FIGURE 32 THE UNITED STATES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 33 CANADA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY EDUCATION
- LESS THAN HIGH SCHOOL
- HIGH SCHOOL GRADUATE
- COLLEGE GRADUATE
- OTHER COLLEGE DEGREES
- MARKET BY AGE GROUP
- 15–24 YEARS
- 25–34 YEARS
- 35–44 YEARS
- ABOVE 44 YEARS
- MARKET BY END-USER
- HOUSEHOLDS
- CLINICS
- HOSPITALS
- MARKET BY DRUGS AND DEVICES
- CONTRACEPTIVES DRUGS
- ORAL CONTRACEPTIVE PILLS
- INJECTABLE CONTRACEPTIVES
- TOPICAL CONTRACEPTIVES
- CONTRACEPTIVE DEVICES
- MALE CONDOMS
- FEMALE CONDOMS
- DIAPHRAGMS
- CONTRACEPTIVE SPONGES
- VAGINAL RINGS
- SUBDERMAL IMPLANTS
- INTRA-UTERINE DEVICES
- COPPER INTRA-UTERINE DEVICES
- HORMONAL INTRA-UTERINE DEVICES
- CONTRACEPTIVES DRUGS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.